Has the balloon really burst? Analysis of “The UK-REBOA Randomized Clinical Trial”
Uncontrolled hemorrhagic shock is a leading cause of early death after injury. Resuscitative endovascular balloon occlusion of the aorta (REBOA) represents a paradigm shift in achieving hemodynamic stability and its implementation still remain controversial in different settings. The recently published UK-REBOA Randomized Clinical Trial aimed to determine the effectiveness of REBOA in patients with hemorrhagic shock, concluding its increased mortality compared with standard care alone.
Source: American Journal of Surgery - Category: Surgery Authors: Andreu Mart ínez Hernández, Rosanna Chorro, Andrés Climent, Francisco G. Lazaro-Paulina, Vicente Martínez García Source Type: research
More News: Clinical Trials | Surgery